RxDoctor Payments Data

Nikola Conrad, MD

Family Medicine · Saint Clair Shores, MINPI 1013279371

Payments from drug & device makers

$996in general payments, 2019–2025

Across 40 payments — averaging $24.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$386
  • AbbVie$173
  • Vivus LLC$120
  • Lilly USA, LLC$44
  • Sanofi Pasteur Inc.$43
  • Organon$30
  • plus $200 from 11 others

What the payments were for

  • Food & beverage$93294%
  • Education$656%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$996 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$34,941
Medicare patients
170
Services billed
484

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$17,546
OzempicSemaglutide13$12,383
MounjaroTirzepatide11$11,556
JardianceEmpagliflozin11$11,211
Spiriva HandihalerTiotropium Bromide12$6,344
Modafinil11$953
Albuterol Sulfate HfaAlbuterol Sulfate34$525
Gabapentin32$407
Pantoprazole Sodium21$401
Rosuvastatin Calcium39$392
Levothyroxine Sodium60$320
Buspirone Hcl21$307
Atorvastatin Calcium49$263
Fluoxetine Hcl25$260
Trazodone Hcl27$242

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$27$17,54611 claims
Novo NordiskOzempic$386$12,38313 claims
Lilly USA, LLCMounjaro$44$11,55611 claims
AbbVieSynthroid$173$12011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Saint Clair Shores

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →